Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal CarcinomaJing Huang, Yuchen Jiao, Xuelian Chen et al.|Clinical Cancer Research|2018Cited by 218
Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in ChinaJing Huang, Binghe Xu, Hongnan Mo et al.|Cancer|2018Cited by 66